These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26429754)

  • 1. Natural course of restless legs syndrome/Willis-Ekbom disease: long-term observation of a large clinical cohort.
    Mitterling T; Heidbreder A; Stefani A; Fritz J; Ulmer H; Poewe W; Högl B
    Sleep Med; 2015 Oct; 16(10):1252-8. PubMed ID: 26429754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.
    Garcia-Borreguero D; Benitez A; Kohnen R; Allen R
    Postgrad Med; 2015; 127(7):716-25. PubMed ID: 26077324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
    Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
    Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willis-Ekbom Disease or Restless Legs Syndrome?
    Carlos K; Prado LB; Carvalho LB; Prado GF
    Sleep Med; 2015 Sep; 16(9):1156-9. PubMed ID: 26298794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.
    Silber MH; Becker PM; Earley C; Garcia-Borreguero D; Ondo WG;
    Mayo Clin Proc; 2013 Sep; 88(9):977-86. PubMed ID: 24001490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.
    Rinaldi F; Galbiati A; Marelli S; Cusmai M; Gasperi A; Oldani A; Zucconi M; Padovani A; Ferini Strambi L
    J Neurol; 2016 Feb; 263(2):396-402. PubMed ID: 26725086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living with Restless Legs Syndrome/Willis-Ekbom Disease.
    Tachibana N
    Sleep Med Clin; 2015 Sep; 10(3):359-67, xv. PubMed ID: 26329446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome/Willis Ekbom disease: evaluation and treatment.
    Allen RP
    Int Rev Psychiatry; 2014 Apr; 26(2):248-62. PubMed ID: 24892899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of the restless legs Syndrome/Willis-Ekbom disease among teenagers, its clinical characteristics and impact on everyday functioning.
    Pienczk-Ręcławowicz K; Pilarska E; Olszewska A; Ręcławowicz D; Konieczna S; Sławek J
    Sleep Med; 2022 Jan; 89():48-54. PubMed ID: 34883398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative sensory test for primary restless legs syndrome/Willis-Ekbom disease using the current perception threshold test.
    Cho YW; Kang MS; Kim KT; Do SY; Lim JG; Lee SY; Motamedi GK
    Sleep Med; 2017 Feb; 30():19-23. PubMed ID: 28215248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
    Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
    Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.
    Allen RP; Picchietti DL; Garcia-Borreguero D; Ondo WG; Walters AS; Winkelman JW; Zucconi M; Ferri R; Trenkwalder C; Lee HB;
    Sleep Med; 2014 Aug; 15(8):860-73. PubMed ID: 25023924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-interval intracortical inhibition is decreased in restless legs syndrome across a range of severity.
    Magalhães SC; Queiroz de Paiva JP; Kaelin-Lang A; Sterr A; Eckeli AL; Winkler AM; Fernandes do Prado G; Amaro E; Conforto AB
    Sleep Med; 2019 Oct; 62():34-42. PubMed ID: 31539846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and quality of life and sleep in children and adolescents with restless legs syndrome/Willis-Ekbom disease.
    Sander HH; Eckeli AL; Costa Passos AD; Azevedo L; Fernandes do Prado LB; França Fernandes RM
    Sleep Med; 2017 Feb; 30():204-209. PubMed ID: 28215250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of Willis-Ekbom disease/restless legs syndrome during and after pregnancy.
    Neyal A; Senel GB; Aslan R; Nalbantoglu M; Acikgoz S; Yilmaz N; Tumay FB; Neyal M; Karadeniz D
    Sleep Med; 2015 Sep; 16(9):1036-40. PubMed ID: 26298776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management.
    García-Borreguero D
    Sleep Med Clin; 2015 Sep; 10(3):287-92, xiii. PubMed ID: 26329438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of Dialysis Patients with Restless Legs Syndrome: A 15-Year Follow-Up Study.
    Baiardi S; Mondini S; Baldi Antognini A; Santoro A; Cirignotta F
    Am J Nephrol; 2017; 46(3):224-230. PubMed ID: 28869939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome.
    Romero-Peralta S; Cano-Pumarega I; García-Borreguero D
    Chest; 2020 Sep; 158(3):1218-1229. PubMed ID: 32247713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome.
    Klingelhoefer L; Bhattacharya K; Reichmann H
    Clin Med (Lond); 2016 Aug; 16(4):379-82. PubMed ID: 27481386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of augmentation and risk factors with long-term follow-up in Japanese patients with restless legs syndrome.
    Tanioka K; Okura M; Inoue M; Taniguchi KI; Taniguchi M; Hamano T; Tachibana N
    Neurol Sci; 2018 Sep; 39(9):1559-1564. PubMed ID: 29845566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.